BOSTON & TOKYO--(BUSINESS WIRE)--HebeCell Corp (HebeCell), a biotechnology company developing ProtoNK™ cell therapeutics based on its proprietary 3D PSC-NK manufacture platform, and Logomix Inc ...
Hebecell Corp. and Logomix Inc. have established a strategic partnership to research and develop gene-edited natural killer (NK) cells and discover genetic modifications that can create ...
SHOREVIEW, Minn.--(BUSINESS WIRE)--Deluxe Corporation (NYSE: DLX) announced that it recently acquired 100 percent of privately held LogoMix, a Boston-based provider of logo design and other small ...
Logomix, a company specializing in cell function engineering, announced on the 30th that it has raised a total of ¥2.8 billion. The investment was made by Angel Bridge, JAFCO, the University of Tokyo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results